| P2093 | author name string | Jian Guo | |
| | Fei Zhou | |
| | Gregory S Basarab | |
| | Camil Joubran | |
| | Karthick Vishwanathan | |
| | Ricardo A Luzietti | |
| P2860 | cites work | Emerging mechanisms of fluoroquinolone resistance | Q24644842 |
| | Structure and mechanism of DNA topoisomerase II | Q27732221 |
| | Discovery and characterization of QPT-1, the progenitor of a new class of bacterial topoisomerase inhibitors | Q33339829 |
| | Exploiting bacterial DNA gyrase as a drug target: current state and perspectives. | Q34214929 |
| | In vitro and in vivo activities of PD 0305970 and PD 0326448, new bacterial gyrase/topoisomerase inhibitors with potent antibacterial activities versus multidrug-resistant gram-positive and fastidious organism groups | Q35758905 |
| | A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system | Q35821755 |
| | The gastrointestinal microbiota as a site for the biotransformation of drugs | Q37235756 |
| | Bacterial DNA replication enzymes as targets for antibacterial drug discovery | Q37998090 |
| | Does mutation in gyrA and/or parC or efflux pump expression play the main role in fluoroquinolone resistance in Escherichia coli urinary tract infections?: A statistical analysis study | Q44439017 |
| | Synthesis of (-)-PNU-286607 by asymmetric cyclization of alkylidene barbiturates | Q44556801 |
| | Fluoroquinolones: mechanisms of action and resistance. | Q54249946 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 158-170 | |
| P577 | publication date | 2014-08-21 | |
| P1433 | published in | Xenobiotica | Q1360678 |
| P1476 | title | In vitro and in vivo metabolism of 14C-AZ11, a novel inhibitor of bacterial DNA gyrase/type II topoisomerase | |
| P478 | volume | 45 | |